You are here: Industry Insights > BioReference

News List

BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry prnewswire
June 23, 2021
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal Caribbean Group, helping provide a safe environment for travelers.
OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test prnewswire
October 22, 2020
BioReference Laboratories, Inc., an OPKO Health company, is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics and health systems throughout the United States, to aid in the diagnosis of ...
OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC) prnewswire
July 21, 2020
BioReference Laboratories, Inc., an OPKO Health company, announced it will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the CDC.